Bile acids are abundant in the mammalian gut, where they undergo bacteria-mediated transformation to generate a large pool of bioactive molecules. Although bile acids are known to affect host metabolism, cancer progression and innate immunity, it is unknown whether they affect adaptive immune cells such as T helper cells that express IL-17a (T H 17 cells) or regulatory T cells (T reg cells). Here we screen a library of bile acid metabolites and identify two distinct derivatives of lithocholic acid (LCA), 3-oxoLCA and isoalloLCA, as T cell regulators in mice. 3-OxoLCA inhibited the differentiation of T H 17 cells by directly binding to the key transcription factor retinoidrelated orphan receptor-γt (RORγt) and isoalloLCA increased the differentiation of T reg cells through the production of mitochondrial reactive oxygen species (mitoROS), which led to increased expression of FOXP3. The isoalloLCA-mediated enhancement of T reg cell differentiation required an intronic Foxp3 enhancer, the conserved noncoding sequence (CNS) 3; this represents a mode of action distinct from that of previously identified metabolites that increase T reg cell differentiation, which require CNS1. The administration of 3-oxoLCA and isoalloLCA to mice reduced T H 17 cell differentiation and increased T reg cell differentiation, respectively, in the intestinal lamina propria. Our data suggest mechanisms through which bile acid metabolites control host immune responses, by directly modulating the balance of T H 17 and T reg cells.
Bile acids are cholesterol-derived natural surfactants that are produced in the liver and secreted into the duodenum. They are critical for lipid digestion, antibacterial defence and glucose metabolism 1 . Although 95% of bile acids are re-absorbed through the terminal ileum of the small intestine and recirculated to the liver, bacteria transform hundreds of milligrams of bile acids to secondary bile acids with unique chemical structures 2, 3 . In the healthy human gut, concentrations of secondary bile acids are in the hundreds of micromolar range 2, 4 . Some bile acids disrupt cellular membranes owing to their hydrophobic nature 5 , whereas other bile acids protect the gut epithelium 6 and confer resistance to pathogens such as Clostridium difficile 7 . Bile acids also influence gut-associated inflammation, which suggests their potential to regulate gut mucosal immune cells 8, 9 . The immune-modulatory effects of bile acids have mostly been studied in the context of innate immunity [10] [11] [12] . A recent study reported the cytotoxic effects of bile acids on gut-residing T cells 13 ; however, whether these acids modulate T cell function directly has not been thoroughly examined. Since the identification of digoxin-a plant-derived molecule that contains a sterol-like core-as the first T H 17 cell inhibitor that binds to RORγt and inhibits its activity 14 , other structurally similar cholesterol derivatives have been identified as RORγt modulators [15] [16] [17] . Because bile acids belong to a family of cholesterol metabolites and exist in the gut (where many T H 17 cells reside 18 ), we reasoned that bile acids control T H 17 cell function by modulating RORγt activity.
Screen for T cell modulatory bile acids
To identify bile acids with modulatory effects on T cells, we screened about 30 compounds. Our screen included both primary bile acids that are synthesized by the host and secondary bile acids that are produced by bacterial modification of primary bile acids (Extended Data Fig. 1 ). Naive CD4 + T cells were isolated from wild-type C57BL/6J (hereafter, B6 Jax) mice and cultured with bile acids under T H 17-cell differentiation conditions and, as a counter-screen, T reg -cell differentiation conditions (Extended Data Fig. 2 ). Notably, two derivatives of LCA were found to substantially affect the differentiation of T H 17 and T reg cells. 3-OxoLCA Article inhibited T H 17 cell differentiation, as shown by reduced expression of IL-17a, and isoalloLCA enhanced T reg cells, as shown by increased FOXP3 expression ( Fig. 1a, b , Extended Data Fig. 2d, e ). Although isoalloLCA strongly enhanced FOXP3 expression in the presence of low-but not high-concentrations of TGFβ (Fig. 1a, Extended Data Fig. 3a-c) , the T reg -cell-enhancing activity of isoalloLCA required TGFβ, as shown by the fact that pretreatment of cells with anti-TGFβ antibody prevented FOXP3 enhancement (Extended Data Fig. 3d, e ).
The modulatory effects of 3-oxoLCA on T H 17 cells, and isoalloLCA on T reg cells, were specific to cell type; neither compound affected T cell differentiation into type 1 or type 2 T helper (T H 1 or T H 2) cells, as assessed by the expression of the cytokines IFNγ and IL-4 and the transcription factors T-bet and GATA3 ( Fig. 1a, b , Extended Data Fig. 3f , g). Although 3-oxoLCA did not affect T reg cells (Fig. 1b , Extended Data Fig. 2e ), isoalloLCA reduced the differentiation of T H 17 cells by about 50% without affecting RORγt expression ( Fig. 1a, b , Extended Data Fig. 3h ). Both compounds exhibited dose-dependent effects (Extended Data Fig. 4a ). 3-OxoLCA did not affect cell proliferation, whereas the addition of isoalloLCA to T cells led to reduced proliferation compared to a dimethylsulfoxide (DMSO) control (Extended Data Fig. 4b ). Treatment with isoalloLCA did not impair cell viability (Extended Data Fig. 4c ) or activation meditated by T cell receptor (TCR), as indicated by a similar expression of markers of TCR activation (such as CD25, CD69, NUR77 and CD44) between isoalloLCA and control treatments (Extended Data Fig. 4d ). TCR activation promotes the enhancement of T reg cells by isoalloLCA; increasing TCR activation with higher concentrations of anti-CD3 resulted in stronger effects on FOXP3 expression, without affecting cell viability (Extended Data Fig. 4e, f ).
3-OxoLCA inhibits T H 17 differentiation
We next examined whether 3-oxoLCA physically interacts with the RORγt protein in vitro. We performed a microscale thermophoresis assay using recombinant human RORγt ligand-binding domain. 3-OxoLCA exhibited a robust physical interaction with the RORγt ligand-binding domain at an equilibrium dissociation constant (K d ) of about 1 μM. We also tested two additional, structurally similar 3-oxo derivatives of bile acids, 3-oxocholic acid (3-oxoCA) and 3-oxodeoxycholic acid (3-oxoDCA) ( Fig. 2a ), and found that these derivatives had about 20 times higher K d values than that of 3-oxoLCA ( Fig. 2b) . Neither 3-oxoCA nor 3-oxoDCA inhibited T H 17 cell differentiation as robustly as did 3-oxoLCA ( Fig. 2c, d ). Next, we examined whether 3-oxoLCA modulates the transcriptional activity of RORγt. We assayed the effect of the bile acids on firefly luciferase expression directed by a fusion protein of RORγt and GAL4 DNA-binding domain in human embryonic kidney (HEK) 293 cells 14 . Cells treated with ML209, a specific RORγt antagonist, completely lost RORγt activity 19 . Similarly, treatment with 3-oxoLCA significantly reduced the activity of the RORγt reporter ( Fig. 2e ). These data suggest that 3-oxoLCA probably inhibits T H 17 cell differentiation by physically interacting with RORγt, and inhibiting its transcriptional activity.
IsoalloLCA promotes T reg differentiation
We next sought to uncover the mechanism by which isoalloLCA exerts its enhancing effects on T reg cells. LCA has a 3α-hydroxyl group as well as a cis 5β-hydrogen configuration at the A-B ring junction and can undergo isomerization, presumably via the actions of gut bacterial enzymes 2 , to form isoLCA (3β,5β), alloLCA (3α,5α) or isoalloLCA (3β,5α) ( Fig. 3a ). Among these LCA isomers, isoalloLCA has the lowest log D value (2.2), comparable to the previously reported 20, 21 log D values of chenodeoxycholic acid (2.2) and ursodeoxycholic acid (2.2) (Extended Data Table 1), which suggests that isoalloLCA is less lipophilic than the other isomers. IsoalloLCA, but not the other LCA isomers, enhanced FOXP3 expression, confirming that both the 3β-hydroxyl group and trans (5α-hydrogen) A-B ring configuration of isoalloLCA are required for enhancement of T reg cells (Fig. 3b ). Compared to cells treated with DMSO, cells treated with isoalloLCA inhibited the proliferation of T effector cells in vitro, indicating they had acquired regulatory activity (Extended Data Fig. 5a, b ). T cells isolated from FOXP3-GFP reporter mice exhibited both increased expression of Foxp3 mRNA ( Fig. 3c ) and enhanced GFP levels after treatment with isoalloLCA (Extended Data Fig. 5c ). Thus, the enhanced expression of FOXP3 induced by isoalloLCA occurs at the level of Foxp3 mRNA transcription.
Foxp3 transcription is regulated by three conserved non-coding enhancers known as CNS1, CNS2 and CNS3 ( Fig. 3d ), each of which has a distinct role in the development, stability and function of T reg cells [22] [23] [24] . Small molecules that promote T reg cells, such as the bacterial metabolite butyrate and the vitamin A derivative retinoic acid, enhance FOXP3 expression in a CNS1-dependent manner 25, 26 . TGFβ also partially requires CNS1 for its T reg -cell-promoting activity, owing to the binding of its downstream signalling molecule SMAD3 to the CNS1 enhancer 24, 27 . Whereas CD4 + T cells from mice with deletions in CNS1 and CNS2 upregulated FOXP3 in response to isoalloLCA, cells respectively, biologically independent samples). A low concentration of TGFβ (0.01 ng ml −1 ) was used for T reg cell culture. DMSO, 3-oxoLCA (20 μM) or isoalloLCA (20 μM) was added on day 0 and CD4 + T cells were gated for analyses on day 3 for T H 17 and T reg cells, and day 5 for T H 1 and T H 2 cells. Data are mean ± s.d., by unpaired t-test with two-tailed P value. that lack CNS3 did not respond ( Fig. 3e , f). By contrast, retinoic acid and TGFβ boosted T reg cell differentiation in CNS3-deficient cells, albeit with reduced efficiency (Extended Data Fig. 5d ). Thus, unlike other small molecules that promote T reg cell differentiation (which do so in a CNS1-dependent manner), the FOXP3-enhancing activity of isoalloLCA requires CNS3.
We investigated other known regulators of T cell function. The transcription factor REL binds to the CNS3 enhancer to induce FOXP3 expression 24 . We found that wild-type and REL-deficient cells express similar levels of FOXP3 upon treatment with isoalloLCA (Extended Data Fig. 5e , f). LCA targets the vitamin D receptor (VDR) 28 and the farnesoid X receptor (FXR) 29 . VDR has also previously been implicated in the modulation of both T H 17 and T reg cell function [30] [31] [32] [33] . Compared to a control treated with DMSO, isoalloLCA-treated cells deficient in VDR or FXR had similar amounts of FOXP3 induction (Extended Data Fig. 5g ). Thus, the CNS3-dependent activation of FOXP3 by isoalloLCA is unlikely to be mediated through the actions of REL, VDR or FXR. VDR and FXR also did not contribute to the suppressive activities of 3-oxoLCA on T H 17 cells (Extended Data Fig. 5h ). Of note, conjugating glycine to 3-oxoLCA or isoalloLCA reduced the immunomodulatory effects of these acids (Extended Data Fig. 5i -k).
CNS3 has previously been implicated in T reg cell development by promoting epigenetic modifications, such as H3K27 acetylation (H3K27ac) and H3K4 methylation, at the Foxp3 promoter region 23 . Compared to cells treated with DMSO, cells treated with isoalloLCA had increased levels of H3K27ac in the Foxp3 promoter region (Extended Data Fig. 6a ). Consistent with this, treatment with isoalloLCA increased recruitment of the histone acetyltransferase p300 (Extended Data Fig. 6b ). However, isoalloLCA did not affect H3K4 methylation (Extended Data Fig. 6c ). The pan-bromodomain inhibitor iBET, which antagonizes H3K27ac, prevented the isoalloLCA-dependent enhancement of FOXP3 in a dosedependent manner (Extended Data Fig. 6d , e). Consistent with previous work 23 , CNS3 deficiency not only reduced basal levels of H3K27ac but also abrogated the isoalloLCA-dependent increase in H3K27ac levels at the Foxp3 promoter region (Extended Data Fig. 6f ). Therefore, CNS3 is probably needed to establish a permissible chromatin landscape, whereupon the promoter region is further acetylated after treatment with isoalloLCA.
MitoROS enhances FOXP3 expression
Cellular metabolism and epigenetic modification are intricately related; for example, the by-products of mitochondrial metabolism serve as substrates for histone acetylation and methylation 34 . T reg cells rely mainly on oxidative phosphorylation for their energy production [35] [36] [37] . Recent studies have identified two metabolites, 2-hydroxyglutarate and d-mannose, that promote T reg cell generation by modulating mitochondrial activities 38, 39 . To assess whether isoalloLCA affects oxidative phosphorylation, we measured the oxygen consumption rate in T cells cultured for 48 h after treatment with DMSO or isoalloLCA. At this time point, FOXP3 is not yet strongly induced, which makes it possible to assess the effects of isoalloLCA on cellular metabolism before cells are fully committed to becoming T reg cells. Compared to DMSO, treatment with isoalloLCA increased the oxygen consumption rate in both wildtype and CNS3-knockout cells (Extended Data Fig. 6g ), suggesting that treatment with isoalloLCA increases mitochondrial activity. Reactive oxygen species (ROS) are produced as by-products of mitochondrial oxidative phosphorylation. Whereas d-mannose increases cytoplasmic ROS production 39 , treatment with isoalloLCA led to increased production of mitoROS without affecting cytoplasmic ROS ( Fig. 3g , Extended Data Fig. 6h , i). Unlike isoalloLCA, other isomers of LCA did not increase mitoROS production ( Fig. 3g ). Furthermore, isoalloLCA-treated cells displayed a modest, but significant increase in total mitochondrial mass and mitochondrial membrane potential (Extended Data Fig. 6j , k). To test whether mitoROS is directly involved in enhanced T reg cell differentiation by isoalloLCA, we used mitoQ (a mitochondrially targeted antioxidant) to reduce ROS levels in mitochondria (Extended Data Fig. 6l ). Importantly, in the presence of mitoQ, isoalloLCA was no longer effective in enhancing T reg cell differentiation ( Fig. 3h , i). By contrast, the retinoic-acid-dependent induction of T reg cells was unaffected by treatment with mitoQ ( Fig. 3h , i). We next investigated whether mitoROS production is responsible for the enhanced levels of H3K27ac at the Foxp3 promoter seen in cells treated with isoalloLCA. Co-treating cells with isoalloLCA and mitoQ decreased levels of H3K27ac, as compared to levels in cells treated with isoalloLCA only (Extended Data Fig. 6m ). Stronger TCR stimulation that enhances FOXP3 expression (Extended Data Fig. 4d , e) also increased mitoROS production 40 (Extended Data Fig. 6n ). Although TGFβ-which is essential for the FOXP3-enhancing Article activity of isoalloLCA (Extended Data Fig. 3d , e)-was not required for increased mitoROS production (Extended Data Fig. 6o ), it was required for the isoalloLCA-induced H3K27ac at the Foxp3 promoter (Extended Data Fig. 6m ). Because FOXP3 itself enhances mitochondrial oxidative phosphorylation 41 , and FOXP3-expressing T reg cells had higher levels of mitoROS than those of other subsets of CD4 + T cells (Extended Data Fig. 6p ), we investigated whether increased mitoROS production was a secondary effect of enhanced FOXP3 expression. CNS3-deficient cells that did not express high levels of FOXP3 in response to treatment with isoalloLCA nevertheless exhibited enhanced oxidative phosphorylation and increased levels of mitoROS ( Fig. 3e , f, Extended Data Fig. 6g , q). We then investigated whether mitoROS is sufficient to promote T reg cell differentiation using the mitochondria-targeted redox cycler, mitoParaquat (mitoPQ) 42 . The addition of mitoPQ to a T cell culture was sufficient to enhance mitoROS production and T reg cell differentiation in a dose-dependent manner (Extended Data Fig. 6r , s). The T reg cell differentiation induced by mitoPQ, similar to that induced by isoalloLCA, required the CNS3 enhancer and TGFβ ( Fig. 3j , k, Extended Data Fig. 6t ). Together, our data support a model in which isoalloLCA promotes T reg cell differentiation by enhancing mitoROS production and increasing H3K27ac at the Foxp3 promoter region, which also requires TGFβinduced signalling (Extended Data Fig. 6u ).
Bile acids set T cell activities in vivo
We next examined whether 3-oxoLCA and isoalloLCA influence T H 17 and T reg cell differentiation in vivo, using a mouse model. Segmented filamentous bacteria (SFB), a murine commensal, are known to induce T H 17 cell differentiation in the small intestine of B6 mice 43 . C57BL/6NTac mice, from Taconic Biosciences (hereafter, B6 Tac), have abundant T H 17 cells in their small intestine, owing to the presence of SFB. By contrast, B6 Jax mice-which lack SFB-have few intestinal T H 17 cells. To determine whether 3-oxoLCA suppresses T H 17 cell differentiation in vivo, we gavaged B6 Jax mice with a faecal slurry containing SFB and fed these mice either a control diet or chow containing 0.3% (w/w) 3-oxoLCA for 1 week (Fig. 4a ). The resulting average concentration of this metabolite in caecal contents was 24 pmol mg −1 of wet mass (approximately equivalent to micromolar) (Extended Data Fig. 7a, b ). This concentration was sufficient to suppress T H 17 differentiation in vitro ( Fig. 1c ). Indeed, treatment with 3-oxoLCA significantly reduced the percentage of ileal T H 17 cells ( Fig. 4b ). When we quantified the average levels of 3-oxoLCA in the stool of human patients with ulcerative colitis or in the caeca of conventionally housed mice, we observed a mean concentration of 23 or 1.0 pmol mg −1 , respectively (Extended Data Fig. 7c, d ). Levels of SFB colonization were comparable between control and 3-oxoLCA-treated groups of mice, which suggests that the change in the percentage of T H 17 cells was not due to a decrease in SFB colonization (Extended Data Fig. 7e ). In addition, B6 Tac mice (which have pre-existing SFB) had reduced percentages of T H 17 cells when fed 3-oxoLCA, compared to when fed with vehicle (Extended Data Fig. 7f -h). Treatment with 3-oxoLCA did not affect percentages of T reg cells (Extended Data Fig. 7i ). Even under the gut inflammatory conditions induced by anti-CD3 injection (which are known to produce a robust T H 17 cell response 18, 44 ), mice treated with 1%-but not with 0.3%-3-oxoLCA had reduced the percentage of T H 17 cells (Extended Data Fig. 7j-l) .
To examine the effects of isoalloLCA on T reg cells in vivo, we fed SFB-colonized B6 Tac mice a control diet or a diet containing 0.03% (w/w) isoalloLCA. IsoalloLCA alone was insufficient to increase the percentage of T reg cells both at steady-state (Extended Data Fig. 7m ) and after treatment with anti-CD3 (Extended Data Fig. 7n ). We noted that 3-oxoLCA further enhanced the T reg cell differentiation induced by isoalloLCA in vitro (Extended Data Fig. 7o observation, administration of a mixture of 0.3% (w/w) 3-oxoLCA and 0.03% (w/w) isoalloLCA significantly enhanced the T reg cell population in mice treated with anti-CD3, compared to that of mice with a control diet ( Fig. 4c, d) . Consistent with the mechanism in vitro, this treatment with the 3-oxoLCA and isoalloLCA mixture led to increased mitoROS production among CD4 + T cells in the ileal lamina propria (Extended Data Fig. 7q ). Importantly, the enhanced expression of FOXP3 induced by the 3-oxoLCA and isoalloLCA mixture in vivo was also dependent on the CNS3 enhancer, as shown by the fact that CNS3-knockout cellsunlike wild-type cells-no longer responded to this treatment in a mixed bone marrow experiment (Fig. 4e, f) . Feeding both isoalloLCA and 3-oxoLCA in chow resulted in an average concentration of 47 pmol mg −1 isoalloLCA in caecal contents (Extended Data Fig. 7b ). This concentration was sufficient to enhance T reg cell differentiation in vitro (Fig. 1c) .
The mean concentration of isoalloLCA in the stool of patients with ulcerative colitis was 2 pmol mg −1 , and ranged between 0 and 17 pmol mg −1 (Extended Data Fig. 7c ). These values are within an order of magnitude of the concentrations observed in mice fed 0.03% isoalloLCA and 0.3% 3-oxoLCA, suggesting that the in vivo levels of isoalloLCA achieved are physiologically relevant. We next asked whether the immunomodulatory roles of 3-oxoLCA and isoalloLCA are mediated through changes in the composition of the gut bacterial community. 16S rDNA sequencing with faecal samples of mice fed diets containing bile acids revealed no substantial perturbations in the gut bacterial community, compared to mice fed a control diet (Extended Data Fig. 8a-e ). Furthermore, treatment with 3-oxoLCA reduced T H 17 cell induction in the colons of germ-free B6 mice infected with Citrobacter rodentium (Extended Data Fig. 8f, g) . Thus, the T H 17 and T reg cell modulatory activities of 3-oxoLCA and isoalloLCA probably do not require the presence of a community of commensal bacteria. These data suggest that both 3-oxoLCA and isoalloLCA directly modulate T H 17 and T reg cell responses in mice in vivo.
Finally, we investigated whether the in vitro treatment of T cells with isoalloLCA produced T reg cells competent to exert suppressive function in vivo. The same number of FOXP3 + T cells (CD45.2), sorted from T cell cultures with low or high TGFβ concentrations (TGFβ low or TGFβ high T reg cells, respectively) in the absence or presence of isoalloLCA, were adoptively transferred into RAG1-knockout mice that had also received CD45RB high naive CD4 + T cells (CD45.1) (Extended Data Fig. 9a, b ). Mice that received CD45RB high or CD45RB high and TGFβ low T reg cells developed substantial weight loss and shortened colon phenotypes, both of which are indicators of symptoms associated with colitis (Extended Data Fig. 9c-f ). By contrast, the adoptive transfer of isoalloLCA-treated T reg cells protected mice from developing symptoms associated with colitis to the same degree as mice that received TGFβ high T reg cells (Extended Data Fig. 9c-f ). T reg cells treated with isoalloLCA were more stable in terms of FOXP3 expression-as compared to TGFβ low T reg cells treated with DMSO-when analysed eight weeks after transfer (Extended Data Fig. 9g-j) . In addition, mice that received isoalloLCA-treated T reg cells had reduced numbers of CD45.1 + T effector cells (Extended Data Fig. 9k ). Therefore, isoalloLCA probably promotes the stability of T reg cells and enhances their function after adoptive transfer in vivo, leading to decreased proliferation of T effector cells.
Discussion
Some bile acids are thought to be tissue-damaging agents that promote inflammation, owing to their enhanced accumulation in patients with liver diseases and their chemical properties as detergents that disrupt cellular membranes 45 . However, recent studies have begun to reveal the antiinflammatory roles of bile acids, particularly in the innate immune system by suppressing NF-κB-dependent signalling pathways 46, 47 and by inhibiting NLRP3-dependent inflammasome activities 11 . Our studies reveal additional anti-inflammatory roles for two LCA metabolites found in both humans and rodents [48] [49] [50] that directly affect CD4 + T cells: 3-oxoLCA suppresses T H 17 cell differentiation and isoalloLCA enhances T reg cell differentiation. Our data suggest that both 3-oxoLCA and isoalloLCA are present in the stool samples of patients with colitis as well as in the 
Fig. 4 | 3-OxoLCA inhibits T H 17 development and isoalloLCA enhances T reg cells in vivo. a, b, Experimental scheme (a) and flow cytometric analysis (b) of T H 17 cell induction by SFB. B6
Jax mice were gavaged with SFB-rich faecal pellets and kept on 3-oxoLCA (0.3%) for a week (n = 11 mice per group). c, d, Experimental scheme (c) and flow cytometric analysis (d) of anti-CD3 experiment with a mixture of 3-oxoLCA + isoalloLCA (n = 10 or 9 mice for control or 3-oxoLCA + isoalloLCA treatment, respectively). B6 Tac mice were intraperitoneally injected with anti-CD3 and fed a control diet or a mixture of 3-oxoLCA (0.3%) + isoalloLCA (0.03%) during the experiments. e, f, Experimental scheme (e) and flow cytometric analysis (f) of T cells isolated from the ileal lamina propria. Bone marrow cells from wild-type (CD45.1) and CNS3-knockout (CD45.2) mice were mixed at a 1:1 ratio and transferred into irradiated wild-type (CD45.1) recipient mice. Five weeks after the transfer, recipient mice were fed a control diet or a diet containing a mixture of 3-oxoLCA (0.3%) + isoalloLCA (0.03%), followed by an anti-CD3 injection (n = 10 mice per group). Data shown as mean ± s.d. by unpaired t-test with twotailed P value.
Article caeca of conventionally-housed B6 Jax mice (Extended Data Fig. 7c, d) . Importantly, both bile acids are completely absent in germ-free B6 mice (Extended Data Fig. 7d ). These data suggest that gut-residing bacteria may contribute to the production of 3-oxoLCA and isoalloLCA, although we cannot rule out the possibility that host enzymes are involved. Given the critical roles of T H 17 and T reg cells in a wide variety of inflammatory diseases and their close relationship with gut-residing bacteria, our study suggests the existence of novel modulatory pathways that regulate T cell function through bile acid metabolites. Future studies to elucidate the bacteria or host enzymes that generate 3-oxoLCA and isoalloLCA will provide the means for controlling T cell function in the context of autoimmune diseases and other inflammatory conditions.
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Methods
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.
Mice C57BL/6, FOXP3-GFP, FXR-knockout, VDR-knockout, CD45.1 and RAG1knockout mice were purchased from the Jackson Laboratory. SFB-containing C57BL/6NTac mice were purchased from Taconic Bioscience. FOXP3-CNS-knockout and control mice were provided by the Y. Zheng laboratory. All mouse procedures were approved by the Institutional Animal Care and Use Committee at Harvard Medical School.
Chemical synthesis of 3-oxoLCA, isoalloLCA, glyco-3-oxoLCA, and glyco-isoalloLCA
Detailed synthesis methods and characterization data are included in Supplementary Information.
Measurement of lipophilicity
Partitioning method. Two microlitres of 10 mM stock solutions of each target compound was added to 1 ml each of 50 mM ammonium bicarbonate (pH = 8), and 1 ml of n-octanol in an Eppendorf tube. The resulting two-phase mixture was vortexed and then shaken for 18 h at 20 °C. The two phases were then carefully separated into the aqueous sample (bottom layer), and organic sample (top layer) and placed separately in autosampler vials and analysed by liquid chromatography with tandem mass spectrometry (LC-MS/MS).
LC-MS method. A Thermo q-Exactive Plus LC-MS equipped with an
Ultimate 3000 HPLC was operated in negative ion mode after optimized to detect the [M − H] − of the bile acids. Mobile phase A was 5 mM ammonium acetate with 0.012% formic acid and mobile phase B was HPLC-grade methanol. A Dikma Inspire C8 column (3-μm particle size, 100-mm length, 4.6-mm inner diameter) was used for analysis. Each injection was 5 μl, and a constant flow rate of 0.400 l/min was used. The gradient started at 0% B and was held constant for 2 min. Then, the mobile phase composition was linearly changed to 100% B over 8 min and held at 100% for the following 5 min. The mobile phase composition was changed to 0% B over the following 0.1 min, and the system was allowed to equilibrate to starting conditions over 1.9 min. Standards of all targets were used to establish retention times. Betterthan-2-ppm mass accuracy was obtained on all measurements. The LC-MS analysis was done in triplicate, and the partitioning was done once for the [M − H] − ion of each target.
Calculation of log D. The total response of target in octanol was divided by the total response in the aqueous phase to get a partitioning coefficient. Then, log 10 was taken and reported.
Human faecal specimens
Faecal samples were obtained from patients with active ulcerative colitis under an Institutional-Review-Board-approved protocol and informed consent was obtained at Weill Cornell Medicine. Active inflammation was defined by a Mayo endoscopic score of > 1.
In vivo bile acid analysis
Stock solutions of all bile acids were prepared by dissolving the compounds in molecular-biology-grade DMSO (Sigma Aldrich). These solutions were used to establish standard curves. Glycocholic acid or β-muricholic acid (Sigma Aldrich) was used as the internal standard for mouse and human samples, respectively. Bile acids were extracted from mouse caecal and human faecal samples, and quantified by ultrahigh-performance liquid chromatography-mass spectrometry (UPLC-MS) as previously reported 51 . The limits of detection of individual bile acids in tissues (in pmol/mg wet mass) are as follows: β-muricholic acid, 0.10; isoalloLCA, 0.45; isoLCA, 0.29; LCA, 0.12; alloLCA, 0.43; and 3-oxoLCA, 0.18.
In vitro T cell culture
Naive CD4 + (CD62L + CD44 − CD25 − CD4 + ) T cells were isolated from the spleens and the lymph nodes of mice of designated genotypes, using FACS. For some experiments, naive CD4 + T cells were enriched using naive CD4 + T cell isolation kits (Miltenyi). Naive CD4 + T cells (40,000 cells) were cultured in a 96-well plate pre-coated with hamster IgG (MP Biomedicals) in T cell medium (RPMI, 10% fetal bovine serum, 25 mM glutamine, 55 μM 2-mercaptoethanol, 100 U/ml penicillin, 100 mg/ ml streptomycin) supplemented with 0.25 μg/ml anti-CD3 (clone 145-2C11) and 1 μg/ml anti-CD28 (clone 37.51). For naive T cell (T H 0) culture, T cells were cultured with the addition of 100 U/ml of IL-2 (Peprotech). For T H 1 cell differentiation, T cells were cultured with the addition of 100 U/ml of IL-2, 10 μg/ml of anti-IL-4 (clone 11B11) and 10 ng/ml of IL-12 (Peprotech). For T H 2 cell differentiation, T cells were cultured with the addition of 10 μg/ml of anti-IFNγ (clone XMG1.2) and 10 ng/ml of IL-4 (R&D Systems). For T H 17 cell differentiation, T cells were cultured with the addition of 10 ng/ml of IL-6 (eBioscience) and 0.5 ng/ml of TGFβ (Peprotech). For T reg cell culture, T cells were cultured with the addition of 100 U/ml of IL-2 and various concentrations of TGFβ. For most in vitro experiments to test the effects of isoalloLCA, no additional TGFβ was added. Bile acids, retinoic acid (Sigma), mitoQ (Focus Biomolecules) or mitoPQ (Sigma) were added either at 0-h or 16-h time points. Compounds with low water solubility were sonicated before adding to the culture. Cells were collected and assayed by flow cytometry on day 3. For ROS and mitochondrial membrane potential detection, cells cultured for 2 days were incubated with 5 μM of mitoSOX (ThermoFisher), 10 μM of DCFDA (Sigma) or 2 μM of JC-1 (ThermoFisher) for 30 min and assayed with flow cytometry.
Flow cytometry
Cells collected from in vitro culture or in vivo mice experiments were stimulated with 50 ng/ml phorbol 12-myristate 13-acetate (PMA) (Sigma) and 1 μM ionomycin (Sigma) in the presence of GolgiPlug (BD) for 4 h to determine cytokine expression. After stimulation, cells were stained with cell-surface marker antibodies and LIVE/DEAD Fixable dye, Aqua, to exclude dead cells, fixed and permeabilized with a FOXP3/ transcription factor staining kit (eBioscience), followed by staining with cytokine-and/or transcription-factor-specific antibodies. All flow cytometry analyses were performed on an LSR II flow cytometer (BD) and data were analysed with FlowJo software (TreeStar).
Cell proliferation assay
Naive CD4 + T cells were labelled with 1 μM carboxyfluorescein succinimidyl ester (CFSE, BioLegend) and cultured for three days before FACS analysis.
In vitro suppression assay
A total of 2.5 × 10 4 freshly purified naive CD4 + CD25 − CD44 − CD62L high T (T conv ) cells from CD45.1 B6 mice were labelled with 1 μM CFSE, activated with soluble anti-CD3 (1 μg/ml) and 5 × 10 4 APCs in 96-well roundbottom plates for 3 days in the presence of tester cells (CD45.2). The CFSE dilution of CD45.1 T conv cells was assessed by flow cytometry.
Mammalian luciferase reporter assay
Reporter assays were conducted as previously described 14 . In brief, 50,000 HEK 293 cells per well were plated in 96-well plates in antibiotic-free Dulbecco's Modified Eagle medium (DMEM) containing 1% fetal calf serum (FCS). Cells were transfected with a DNA mixture containing 0.5 μg/ml of firefly luciferase reporter plasmid (Promega pGL4.31 (luc2P/Gal4UAS/Hygro)), 2.5 ng/ml of a plasmid containing Renilla luciferase (Promega pRL-CMV), and GAL4-DNA binding domain-RORγ (0.2 μg/ml). Transfections were performed using TransIT-293 (Mirus) according to the manufacturer's instruction. Bile acids or vehicle control were added 24 h after transfection and luciferase activity was measured 16 h later using the dual-luciferase reporter kit (Promega).
Microscale thermophoresis assay
The binding affinity of the compounds with RORγ ligand-binding domain was analysed by microscale thermophoresis (MST). Purified RORγ ligand-binding domain was labelled with the Monolith NT Protein Labelling Kit RED (NanoTemper Technologies). Serially diluted compounds, with concentrations of 1 mM to 20 nM, were mixed with 55 nM labelled RORγ ligand-binding domain at room temperature and loaded into Monolith standard-treated capillaries. Binding was measured by monitoring the thermophoresis with 20% LED power and 'medium' MST power on a Monolith NT.115 instrument (Nano Temper Technologies) with the following time setting: 5 s Fluo, before; 20 s MST on; and 5 s Fluo, after. K d values were fitted using the NT Analysis software (Nano Temper Technologies).
qPCR with reverse transcription
Total RNA was isolated from cultured T cells using an RNeasy kit (Qiagen) and reverse-transcribed using a PrimeScript RT kit (Takara). All qPCRs were run on the Bio-Rad CFX real-time system using iTaq Universal SYBR Green Supermix (Bio-Rad). β-Actin was used as an internal control to normalize the data across different samples. Primers used for qPCR were as follows: Foxp3 forward (-F), 5′-ACTGGGGTCTTCTCCCTCAA-3′; Foxp3 reverse (-R), 5′-CGTGGGAAGGTGCAGAGTAG-3′; Actb-F, 5′-CGCC ACCAGTTCGCCATGGA-3′; Actb-R, 5′-TACAGCCCGGGGAGCATCGT-3′.
Metabolic assays
In vitro differentiated cells were cultured in the presence of DMSO or isoalloLCA for 48 h, and washed extensively before the assay. The oxygen consumption rate was determined using a Seahorse XF96 Extracellular Flux Analyzer (Seahorse Bioscience) following protocols recommended by the manufacturer and according to the previously published method 52 . In brief, cells were seeded on XF96 microplates (150,000 cells per well) that had been pre-coated with poly-d-lysine (Sigma) to immobilize cells. Cells were maintained in XF medium in a non-CO 2 incubator for 30 min before the assay. The Mito stress test kit (Agilent) was used to test the oxygen consumption rate by sequential injection of 1 μM oligomycin, 1.5 μM FCCP (carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone) and 0.5 μM rotenone or antimycin A. Data were analysed by wave software (Agilent).
Chromatin immunoprecipitations
Chromatin immunoprecipitation (ChIP) assays were performed according to a standard protocol. In brief, naive CD4 + T cells were cultured for 48 h, and fixed for 10 min with 1% formaldehyde. Then, 0.125 M glycine was added to quench the formaldehyde. Cells were lysed, and chromatin was collected and fragmented by sonication at a concentration of 10 7 cells per ChIP sample. Chromatin was immunoprecipitated with 5 μg of ChIP or IgG control antibodies at 4 °C overnight and incubated with protein G magnetic beads (Ther-moFisher) at 4 °C for 2 h, washed and eluted in 150 μl elution buffer. Eluate DNA and input DNA were incubated at 65 °C to reverse the crosslinking. After digestion with proteinase K, DNA was purified with the QIAquick PCR purification kit (Qiagen). The relative abundance of precipitated DNA fragments was analysed by qPCR using SYBR Green Supermix (Bio-Rad). The primers used were as follows: Foxp3 promoter-F, 5′-TAATGTGGCAGTTTCCCACAAGCC-3′; Foxp3 promoter-R, 5′-AATACCTCTCTGCCACTTTCGCCA-3′; Foxp3 CNS1-F, 5′-AGACTGTCTGGAACAACCTAGCCT-3′; Foxp3 CNS1-R, 5′-TGGAGGT ACAGAGAGGTTAAGAGCCT-3′; Foxp3 CNS2-F, 5′-ATCTGGCCAAGTTCA GGTTGTGAC-3′; Foxp3 CNS2-R, 5′-GGGCGTTCCTGTTTGACTGTTTCT-3′;
Foxp3 CNS3-F, 5′-TCTCCAGGCTTCAGAGATTCAAGG-3′; Foxp3 CNS 3-R, 5′-ACAGTGGGATGAGGATACATGGCT-3′; Foxp3 ex10-F, 5′-CT GCATCGTAGCCACCAGTA-3′; Foxp3 ex10-R, 5′-AACTATTGCCAT GGCTTCC-3′; Hsp90ab1-F, 5′-TTACCTTGACGGGAAAGCCGAGTA-3′; Hsp90ab1-R, 5′-TTCGGGAGCTCTCTTGAGTCACC-3′.
Isolation of lamina propria lymphocytes
Gut tissues were collected and treated with 1 mM DTT at room temperature for 10 min, and 5 mM EDTA at 37 °C for 20 min to remove epithelial cells, and dissociated in digestion buffer (RPMI, 1 mg/ml collagenase type VIII, 100 μg/ml DNase I and 5% FBS) with constant stirring at 37 °C for 30 min. Mononuclear cells were collected at the interface of a 40%-80% Percoll gradient (GE Healthcare). Cells were then analysed by flow cytometry. The distal one-third of the small intestines was considered the ileum.
Mouse experiments
For bile-acid feeding experiments, the standard mouse diet in ground meal format (PicoLab Diet, no. 5053) was evenly mixed with a measured amount of bile acid compounds and provided in glass feeder jars and replenished when necessary. Bile-acid feeding experiments were performed for seven days or less as extended feeding sometimes resulted in reduced food consumption and weight loss. Colonization of mice with SFB was done with fresh faecal samples, derived from Il23r -/-Rag2 -/double-knockout mice that are known to carry much higher levels of SFB compared to conventional B6 mice. Faecal samples were homogenized in water using a 70-μm cell strainer and a 5-ml syringe plunger. Supernatant was introduced into mice using a 20G gavage needle at 250 μl per mouse, approximately equal to the amount of 1/4 mouse faecal pellets. Successful colonization was assessed by qPCR, using the following primers: SFB-F, 5′-GACGCTGAGGCATGAGAG CAT-3′; SFB-R, 5′-GACGGCACGAATTGTTATTCA-3′; universal 16S-F, 5′-ACTCCTACGGGAGGCAGCAGT-3′; universal 16S-R, 5′-ATTACCGCGG CTGCTGGC-3′. For the C. rodentium infection experiment, age-and sex-matched germ-free mice were orally infected with approximately 1 × 10 6 colony-forming units of C. rodentium and killed for analysis at 6 days after infection. Mice were kept in IsoCage system (Tecniplast) and fed an autoclaved diet with or without 0.3% 3-oxoLCA (w/w) during the experiment.
Bone marrow transfer
Bone marrow cells were isolated from the femur and tibia of B6 (CD45.1) mice or of CNS3-knockout mice (CD45.2). Red blood cells were removed by using an ammonium-chloride-potassium lysing buffer. The two populations were mixed at a 1:1 ratio and a total of 1 × 10 7 cells were transferred into each irradiated (1,000 rad) CD45.1 mouse (5 weeks old) by retro-orbital injection. Sulfamethoxazoletrimethoprim (240 mg in 250 ml drinking water) was provided for 2 weeks after irradiation.
Adoptive transfer colitis CD45RB high adoptive transfer colitis was performed as previously described 53 . In brief, isolated CD4 + CD25 − CD45RB high naive T cells were sorted from wild-type B6 (CD45.1) mice by FACS and 0.5 million cells were adoptively transferred into each RAG1-knockout recipient mouse. In addition, the same number of in vitro cultured and sortpurified CD45.2 + FOXP3-GFP + cells were transferred into the recipient mice. Naive CD4 T cells, isolated from CD45.2 FOXP3-IRES-GFP mice, were cultured under TGFβ low (0.05 ng/ml TGFβ), isoalloLCA (20 μM isoalloLCA and 0.01 ng/ml TGFβ) or TGFβ high (1 ng/ml TGFβ) conditions. Mice were then monitored and weighed each week. At week 8, colon tissues were collected, and lamina propria lymphocytes were analysed by flow cytometry. Haematoxylin and eosin (H & E) staining and disease scoring were performed by the Rodent Histopathology Core at Harvard Medical School.
Isolation of faecal bacterial microbiota and 16S rRNA gene sequencing analysis
DNA of the mouse faecal microbiota was isolated by using QIAamp Fast DNA Stool Mini Kit (Qiagen) according to the manufacturer's instructions. The samples were quantified using an Agilent 4200 Tapestation instrument, with corresponding Agilent Genomic DNA ScreenTape assays. The samples were then normalized to 12.5 ng of input in 2.5 μl (5 ng/μl), and amplified using IDT primers specific to the V3 and V4 region: forward 5′-TCGTCGGCAGCGTCAGATGTGTATAAG AGACAGCCTACGGGNGGCWGCAG-3′, reverse 5′-GTCTCGTGGGCTCGG AGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3′. The amplification was done using the KAPA HiFi HotStart Ready Mix (2×) (Roche Sequencing Solutions). Residual primers were eluted away using Aline PCRCLean DX beads in a 0.8× SPRI-based cleanup. The purified amplicons were then ligated with indexing adapters using Illumina's Nextera XT Index Primers. Following this step, a final clean-up was performed using Aline PCRClean DX beads. The resulting purified libraries were run on an Agilent 4200 Tapestation instrument, with a corresponding Agilent High Sensitivity D1000 ScreenTape assay to visualize the libraries and check that the size of the library matched the expected about 630-bp product. Concentrations obtained from this assay were used to normalize all samples in equimolar ratio. The pool was denatured and loaded onto an Illumina MiSeq instrument, with an Illumina MiSeq V3 600-cycle kit to obtain paired-end 300-bp reads. The pool was loaded at 10.5 pM, with 50% PhiX spiked in to compensate for low base diversity. The basecall files were demultiplexed through the BioPolymer Facility's pipeline, and the resulting FASTQ files were used in subsequent analysis. Raw fastq sequences were then quality-filtered and analysed by following QIIME2 version 2018.11 and DADA2 1.6.0 [54] [55] [56] . Operational taxonomic units were picked with 97% sequence similarity. The phylogenetic affiliation of each operational taxonomic unit was aligned to the Greengenes reference database version 13_8 and 99% ID. Last updated by author(s): Sep 5, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
FlowJo V9.9.3, V10.6.0 software(TreeStar), Wave V2.6.1 (Agilent), GraphPadPrism V7 (GraphPad Software), RStudio V1. 2.1335 For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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